Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

IREX vs WULX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

WULX Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–0 Matrix Metrics)

WULX Overall Winner 6-Pillar Tally: IREX 0 – 0 WULX (6 Tie) Matrix Metrics: IREX 0 – 2 WULX

As of Nov 20, 2026, WULX (WULX) is the stronger overall head-to-head candidate over IREX (IREX) in the Tradestie Institutional Equity Comparison Engine, winning 2–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). IREX carries a Unified Composite Score of 40.6/100 (SELL) at $0.81 (N/M Forward P/E, N/A operating margin), whereas WULX carries 46.9/100 (HOLD) at $4.45 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: IREX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.2); meanwhile WULX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IREX vs WULX
IREX US Equity
IREX
Institutional Equity
$0.81
-36.22% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 7.85β · 281% Vol
Unified Composite Score
40.6 / 100 SELL
Tech 25.0 Fund 49.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -36.2%), weak momentum, RSI 25
RSI-14: 25.2 · SMA20: $3.04 · SMA50: $8.33
WULX US Equity Head-to-Head Winner
WULX
Institutional Equity
$4.45
-30.03% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 7.00β · 249% Vol
Unified Composite Score
46.9 / 100 HOLD
Tech 40.0 Fund 44.0 Flow 50.0 Mom 74.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -26.4%), weak momentum, RSI 36
RSI-14: 36.0 · SMA20: $7.19 · SMA50: $10.11

6-Pillar Scorecard Institutional Category Breakdown (IREX 0 – 0 WULX)

Columns: Metric · IREX · WULX
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 274.1% (80th %ile) 200.1% (10th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IREX (0) vs WULX (2)
Institutional Metric IREX WULX Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
0% ($1–$61) 0% ($4–$68) Stronger Trend Tie
Beta / 30D Volatility
Risk Regime
7.85β · 281% Vol 7.00β · 249% Vol Lower Realized Risk WULX
Unified Institutional Score
Composite Signal
40.6 / 100 (SELL) 46.9 / 100 (HOLD) Higher Composite WULX
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon WULX +47.93 pp
IREX: -83.16% · WULX: -35.23%
3M Horizon WULX +23.57 pp
IREX: -94.12% · WULX: -70.55%
6M Horizon WULX +8.39 pp
IREX: -97.99% · WULX: -89.6%
1Y Horizon WULX +16.51 pp
IREX: -95.3% · WULX: -78.79%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IREX vs WULX. Trailing 12-month operating profitability (IREX N/A vs WULX N/A) and valuation multiples (IREX N/M vs WULX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

IREX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
WULX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IREX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 274.1%
IV Percentile 80th %ile
Put/Call OI Skew N/A
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IREX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
WULX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 200.1%
IV Percentile 10th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact WULX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IREX Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
WULX Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ IREX vs WULX Key Questions & Quantitative Answers

As of Nov 20, 2026, WULX (WULX) is the stronger overall head-to-head candidate over IREX (IREX) in the Tradestie Institutional Equity Comparison Engine, winning 2–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). IREX carries a Unified Composite Score of 40.6/100 (SELL) at $0.81 (N/M Forward P/E, N/A operating margin), whereas WULX carries 46.9/100 (HOLD) at $4.45 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: IREX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.2); meanwhile WULX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

IREX and WULX split Growth & Scale metrics: IREX posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with WULX at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, IREX generates N/A in USD-normalized revenue versus N/A for WULX. In operating R&D and SG&A reinvestment, IREX deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for WULX.

IREX and WULX trade at balanced relative valuation multiples. IREX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas WULX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IREX (N/A ROE) versus WULX (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, IREX carries 274.1% implied volatility (80th %ile, Elevated (60th–80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (7.85β · 281% Vol realized risk). By comparison, WULX carries 200.1% implied volatility (10th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (7.00β · 249% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.